News & Publications

On June 9, 2017, Hutch news published Rose Wittman's Merkel cell carcinoma story as she failed to qualify for one clinical trial, but a later experimental treatment sent her into complete remission. To read more, view the article here. Furthermore, Fred Hutch has provided a medium for individual...

On May 31, 2017, Hutch News released an article highlighting the promising results from an ongoing early-stage trial. The combination of T-cell therapy, avelumab (the newly FDA- approved drug), followed by an immune booster has kept cancer from progressing in three out of four patients with metasta...

On May 9, 2017, Dermatology News published an article discussing the importance in conducting surveillance for recurrence in Merkel cell carcinoma. A two year retrospective cohort study conducted by Ms. Aubriana McEvoy and other colleagues, under the guidance of Dr. Paul Nghiem, has laid the foundat...

The 13th Congress of the European Association of Dermato-Oncology (EADO) was held in Athens, Greece on May 3-6, 2017 at the Megaron Athens International Conference Center. The event highlighted some of the major aspects of Merkel cell carcinoma, melanoma, and various other skin cancers. Dr. Nghiem ...

American Academy of Dermatology Annual Meeting Orlando, FL Prepared by Drs. Song Park, Paul Nghiem and Hannah Thomas  Announcements: If you are interested in presenting at next year’s MMIG meeting in San Diego, California on Friday February 16th, 2018 (5 – 7 pm), please send Paul...

A team in France has developed a similar test for antibodies to the Merkel virus oncoprotein. Information about getting the test performed in Europe can be found HERE. 

On April 6, 2017, the SCCA published an article on the newly FDA approved treatment for Merkel cell carcinoma. “While skin cancer is one of the most common cancers, patients with a rare form called Merkel cell carcinoma have not had an approved treatment option until now,” said Dr. Richard Pazd...

Until recently, patients with the rare skin cancer Merkel cell carcinoma could expect to live just months after it started spreading and became resistant to chemotherapy. But, less than two weeks ago, everything changed. And today things are looking even better. On March 23, the immunotherapy drug a...

For as long as I can remember, I have been captivated by the idea of belonging to a dynamic team that explores a frontier relevant to humanity. Some of my earliest childhood memories were of being transfixed by NASA’s Apollo missions to the moon. Like many of my friends, I dreamed of becoming an a...

Aim: Merkel cell carcinoma (MCC) is a rare neuroendocrine, cutaneous malignancy with poor prognosis once metastasized. The aim of this study was to conduct a systematic literature review to assess clinical outcomes associated with chemotherapy regimens in metastatic MCC. Materials & Methods: Embase�...